SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
7 hedge funds and large institutions have $12.4K invested in Syros Pharmaceuticals, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-36
Holders Change %
-83.72%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
1
Closed
37
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.19K |
| 2 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$1.41K |
Top Sellers
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$632K |
| 2 |
BlackRock
New York
|
-$63.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$61.7K |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$57.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$45.1K |
